Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Trends in Biotechnology
|
April 9, 2021
Potency Meets Precision in Nano-optimized Chemotherapeutics
Artavazd Arumov, Asaad Trabolsi, Jonathan H Schatz
Blood Cancer Journal
|
February 8, 2024
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Asaad Trabolsi, Artavazd Arumov, Jonathan H Schatz
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2019
T Cell-Activating Bispecific Antibodies in Cancer Therapy
Asaad Trabolsi, Artavazd Arumov, Jonathan H Schatz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 2, 2025
Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline
Toral Shastri, Asaad Trabolsi, Artavazd Arumov, et al.
Leukemia & Lymphoma
|
November 7, 2023
Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma
Austin D Newsam, Caroline A Coughlin, Asaad Trabolsi, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2017
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
Julia Escandon, Stephanie Peacock, Asaad Trabolsi, et al.
Leukemia & Lymphoma
|
October 21, 2021
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast
Sunil Girish Iyer, Russ Kuker, Jorge A Florindez, et al.
Blood Vessels, Thrombosis & Hemostasis
|
August 6, 2025
Association of risk factors for venous thromboembolism and overall survival in lung cancer
Thomas E Plate, Asaad Trabolsi, Rachel S Kronenfeld, et al.
Leukemia & Lymphoma
|
December 20, 2021
Marginal zone lymphoma of the colon: case series from a single center and SEER data review
Asaad Trabolsi, Juan Pablo Alderuccio, Jorge Florindez, et al.
Leukemia & Lymphoma
|
March 20, 2026
Predictors and timing of venous thromboembolism and overall survival in lymphoma
Asaad Trabolsi, Thomas E Plate, Tessa Lavorgna, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Trends in Biotechnology
|
April 9, 2021
Potency Meets Precision in Nano-optimized Chemotherapeutics
Artavazd Arumov, Asaad Trabolsi, Jonathan H Schatz
Blood Cancer Journal
|
February 8, 2024
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Asaad Trabolsi, Artavazd Arumov, Jonathan H Schatz
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2019
T Cell-Activating Bispecific Antibodies in Cancer Therapy
Asaad Trabolsi, Artavazd Arumov, Jonathan H Schatz
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 2, 2025
Bispecific Antibodies in Hematologic Malignancies: Attacking the Frontline
Toral Shastri, Asaad Trabolsi, Artavazd Arumov, et al.
Leukemia & Lymphoma
|
November 7, 2023
Functional drivers of resistance to anti-CD19 CAR-T cell therapy in diffuse large B cell lymphoma
Austin D Newsam, Caroline A Coughlin, Asaad Trabolsi, et al.
Journal for Immunotherapy of Cancer
|
January 21, 2017
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor
Julia Escandon, Stephanie Peacock, Asaad Trabolsi, et al.
Leukemia & Lymphoma
|
October 21, 2021
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast
Sunil Girish Iyer, Russ Kuker, Jorge A Florindez, et al.
Blood Vessels, Thrombosis & Hemostasis
|
August 6, 2025
Association of risk factors for venous thromboembolism and overall survival in lung cancer
Thomas E Plate, Asaad Trabolsi, Rachel S Kronenfeld, et al.
Leukemia & Lymphoma
|
December 20, 2021
Marginal zone lymphoma of the colon: case series from a single center and SEER data review
Asaad Trabolsi, Juan Pablo Alderuccio, Jorge Florindez, et al.
Leukemia & Lymphoma
|
March 20, 2026
Predictors and timing of venous thromboembolism and overall survival in lymphoma
Asaad Trabolsi, Thomas E Plate, Tessa Lavorgna, et al.
Page
of 2